Related Experiment Video
Updated: Jan 31, 2026
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
CD44 Orchestrates Metastatic Teamwork
Christine L Chaffer1, Jacky G Goetz2
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, UNSW Medicine, UNSW Sydney, Australia.
Abstract:
Inhibition of metastatic cancer cell colonization and outgrowth is arguably one of the greatest therapeutic challenges. Reporting in Cancer Discovery, Liu et al. (2018) describe how homophilic interactions of CD44, a classical breast cancer stem cell marker, drive tumor cell aggregation outside the primary tumor to augment their metastatic potential.
Insights
Breast cancer stem cell marker CD44 promotes tumor cell aggregation and metastasis through homophilic interactions. Inhibiting these interactions could be a therapeutic strategy against cancer spread.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Biology
Background:
- Metastatic cancer colonization and outgrowth remain significant therapeutic challenges.
- CD44 is a well-established marker for breast cancer stem cells.
- Tumor cell aggregation outside the primary tumor is critical for metastasis.
Purpose of the Study:
- To investigate the role of CD44 in driving tumor cell aggregation.
- To understand how CD44-mediated aggregation contributes to metastatic potential.
- To explore potential therapeutic targets for inhibiting cancer metastasis.
Main Methods:
- Analysis of CD44 expression in breast cancer cells.
- Investigating homophilic CD44 interactions.
- Assessing the impact of CD44 aggregation on metastatic outgrowth in preclinical models.
Main Results:
- Homophilic interactions of CD44 were identified as a key driver of tumor cell aggregation.
- CD44-mediated aggregation outside the primary tumor enhances metastatic potential.
- Targeting CD44 interactions may impede cancer cell colonization.
Conclusions:
- CD44-mediated cell aggregation is a crucial mechanism promoting breast cancer metastasis.
- Inhibiting CD44 homophilic interactions represents a potential therapeutic strategy to prevent metastatic disease.
